NDC 42192-331 – NP Thyroid 90
Levothyroxine 57 ug/1; Liothyronine 13.5 ug/1 · Tablet · Oral
Product NDC42192-331
Product details
- Brand name
- NP Thyroid 90
- Generic name
- Levothyroxine, Liothyronine
- Labeler
- Acella Pharmaceuticals, LLC
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- UNAPPROVED DRUG OTHER
- Marketed since
- February 3, 2011
- Listing expires
- December 31, 2027
- Pharmacologic class
- l-Thyroxine; l-Triiodothyronine
Active ingredients
- Levothyroxine 57 ug/1
- Liothyronine 13.5 ug/1
Package NDC codes (4)
| Package NDC | Description | Since |
|---|---|---|
| 42192-331-01 | 100 TABLET in 1 BOTTLE (42192-331-01) | Feb 3, 2011 |
| 42192-331-10 | 1000 TABLET in 1 BOTTLE (42192-331-10) | Mar 3, 2025 |
| 42192-331-30 | 30 TABLET in 1 BOTTLE (42192-331-30) | Mar 3, 2025 |
| 42192-331-90 | 90 TABLET in 1 BOTTLE (42192-331-90) | Dec 1, 2025 |
Recalls mentioning this NDC
- D-0396-2021 Jun 2, 2021 · Class I
Subpotent Drug - D-0397-2021 Jun 2, 2021 · Class I
Subpotent Drug - D-0399-2021 Jun 2, 2021 · Class I
Subpotent Drug - D-0398-2021 Jun 2, 2021 · Class I
Subpotent Drug - D-0395-2021 Jun 2, 2021 · Class I
Subpotent Drug - D-0035-2021 Oct 28, 2020 · Class I
Subpotent Drug: FDA analysis found these products to be less than the labeled claim for the levothyroxine (T4) portion of the product. - D-0036-2021 Oct 28, 2020 · Class I
Subpotent Drug: FDA analysis found these products to be less than the labeled claim for the levothyroxine (T4) portion of the product. - D-1299-2020 Jun 10, 2020 · Class I
Superpotent Drug. - D-1298-2020 Jun 10, 2020 · Class I
Superpotent Drug. - D-1300-2020 Jun 10, 2020 · Class I
Superpotent Drug.
Other NP Thyroid 90 products
- 50090-5229 Levothyroxine 57 ug/1; Liothyronine 13.5 ug/1 · Tablet · A-S Medication Solutions
- 76420-569 Levothyroxine 57 ug/1; Liothyronine 13.5 ug/1 · Tablet · Asclemed USA, Inc.